Woad entered the final round of the KPMG Women’s Irish Open with a whopping seven-stroke lead. Although Sagström was the ...

The post 2025 KPMG Women’s Irish Open final results: Prize money payout and Ladies European Tour leaderboard first appeared ...

PARIS, FRANCE, 06 May 2025 – Ipsen (Euronext: IPN; ADR: IPSEY), a global specialty care-driven biopharmaceutical company, announced today the appointment of Laura Réveillon, PhD as EVP ...

PARIS, FRANCE, 16 April 2025 - Ipsen (Euronext: IPN; ADR: IPSEY), a global specialty-care biopharmaceutical company, today presents sales for the first quarter of 2025.

“We are pleased with the outcome of this inaugural Rated Public Bond that reinforces and demonstrates investor’s confidence in Ipsen’s Investment Grade credit profile and long-term strategy,” said ...

Ipsen is a global biotechnology company headquartered in France that develops and commercializes medicines across three therapeutic areas: oncology, neuroscience, and rare diseases. Ipsen was ...

Ipsen SA (IPSEF) reports robust financial performance with a 9.9% sales increase and strategic pipeline developments, despite facing competitive pressures.

Discover Ipsen's strong Q4 2024 earnings, with 9.9% sales growth and key pipeline successes.

Ipsen announced today that the National Institute for Health and Care Excellence (NICE) has recommended elafibranor 80mg tablets for the treatment of PBC in combination with ursodeoxycholic acid ...

Pictured: Lorraine Ivory-Corr, Senior Broker Consultant, Royal London Ireland This week sees new and notable appointments at Royal London Ireland, Ipsen, Suir Engineering, Vantiva, Avacta and Nokia.

Ipsen’s Dublin, Ireland site has almost 200 employees and produces the active pharmaceutical ingredients for two of Ipsen’s medicines. “It’s truly an honor to receive this second Shingo Prize,” said ...

Ipsen’s Dublin, Ireland site has almost 200 employees and produces the active pharmaceutical ingredients for two of Ipsen’s medicines.